Combining Biomarkers and Imaging for Short-Term Assessment of Cardiovascular Disease Risk in Apparently Healthy Adults
Author
Gore, Maria OdetteAyers, Colby R
Khera, Amit
deFilippi, Christopher R
Wang, Thomas J
Seliger, Stephen L
Nambi, Vijay
Selvin, Elizabeth
Berry, Jarett D
Hundley, W Gregory
Budoff, Matthew
Greenland, Philip
Drazner, Mark H
Ballantyne, Christie M
Levine, Benjamin D
de Lemos, James A
Date
2020-07-23Journal
Journal of the American Heart AssociationPublisher
Wiley-BlackwellType
Article
Metadata
Show full item recordAbstract
Background Current strategies for cardiovascular disease (CVD) risk assessment focus on 10-year or longer timeframes. Shorter-term CVD risk is also clinically relevant, particularly for high-risk occupations, but is under-investigated. Methods and Results We pooled data from participants in the ARIC (Atherosclerosis Risk in Communities study), MESA (Multi-Ethnic Study of Atherosclerosis), and DHS (Dallas Heart Study), free from CVD at baseline (N=16 581). Measurements included N-terminal pro-B-type natriuretic peptide (>100 pg/mL prospectively defined as abnormal); high-sensitivity cardiac troponin T (abnormal >5 ng/L); high-sensitivity C-reactive protein (abnormal >3 mg/L); left ventricular hypertrophy by ECG (abnormal if present); carotid intima-media thickness, and plaque (abnormal >75th percentile for age and sex or presence of plaque); and coronary artery calcium (abnormal >10 Agatston U). Each abnormal test result except left ventricular hypertrophy by ECG was independently associated with increased 3-year risk of global CVD (myocardial infarction, stroke, coronary revascularization, incident heart failure, or atrial fibrillation), even after adjustment for traditional CVD risk factors and the other test results. When a simple integer score counting the number of abnormal tests was used, 3-year multivariable-adjusted global CVD risk was increased among participants with integer scores of 1, 2, 3, and 4, by ≈2-, 3-, 4.5- and 8-fold, respectively, when compared with those with a score of 0. Qualitatively similar results were obtained for atherosclerotic CVD (fatal or non-fatal myocardial infarction or stroke). Conclusions A strategy incorporating multiple biomarkers and atherosclerosis imaging improved assessment of 3-year global and atherosclerotic CVD risk compared with a standard approach using traditional risk factors.Keyword
N‐terminal pro B‐type natriuretic peptidecarotid intima‐media thickness
coronary artery calcium
high‐sensitivity C‐reactive protein
high‐sensitivity cardiac troponin T
plaque
Identifier to cite or link to this item
http://hdl.handle.net/10713/13556ae974a485f413a2113503eed53cd6c53
10.1161/JAHA.119.015410